All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC1066 | Human anti-SEC24A T cell receptor (A14), pCDTCR1 | A14 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1067 | Human anti-SEC24A T cell receptor (A22), pCDTCR1 | A22 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1068 | Human anti-SEC24A T cell receptor (A8), pCDTCR1 | A8 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1069 | Human anti-SEC24A T cell receptor (AA12), pCDTCR1 | AA12 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1070 | Human anti-SEC24A T cell receptor (AB8), pCDTCR1 | AB8 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1071 | Human anti-SEC24A T cell receptor (AC12), pCDTCR1 | AC12 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1072 | Human anti-SEC24A T cell receptor (BB11), pCDTCR1 | BB11 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1073 | Human anti-SEC24A T cell receptor (BB8), pCDTCR1 | BB8 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1074 | Human anti-SEC24A T cell receptor (C23), pCDTCR1 | C23 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1075 | Human anti-SEC24A T cell receptor (C7), pCDTCR1 | C7 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1076 | Human anti-SEC24A T cell receptor (CE4), pCDTCR1 | CE4 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1077 | Human anti-SEC24A T cell receptor (F23), pCDTCR1 | F23 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1078 | Human anti-SEC24A T cell receptor (F9), pCDTCR1 | F9 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1079 | Human anti-SEC24A T cell receptor (FF5), pCDTCR1 | FF5 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1080 | Human anti-SEC24A T cell receptor (G15), pCDTCR1 | G15 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1081 | Human anti-SEC24A T cell receptor (GA9), pCDTCR1 | GA9 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1082 | Human anti-SEC24A T cell receptor (GC4), pCDTCR1 | GC4 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1083 | Human anti-SEC24A T cell receptor (GC6), pCDTCR1 | GC6 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1084 | Human anti-SEC24A T cell receptor (IC5), pCDTCR1 | IC5 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector | ||
TCR-YC1085 | Human anti-SEC24A T cell receptor (JA6), pCDTCR1 | JA6 | Human | FLYNLLTRV | HLA-A2 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION